McIlrath & Eck’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
McIlrath & Eck's PTCT Position: Q3 2026 in Review
McIlrath & Eck opened a new position in PTC Therapeutics (PTCT) in Q3 2026: 51 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #790 among its holdings.
361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- McIlrath & Eck held 51 shares of PTC Therapeutics worth $3.3K as of Q3 2026.
- PTC Therapeutics was a new McIlrath & Eck position in Q3 2026.
- PTC Therapeutics made up ﹤0.01% of McIlrath & Eck's portfolio in Q3 2026, its #790 holding.
- 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on McIlrath & Eck's 13F filing for Q3 2026, filed 17 Nov 2026.